Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Non-indigenous species refined national baseline inventories: A synthesis in the context of the European Union's Marine Strategy Framework Directive.

Tsiamis K, Palialexis A, Stefanova K, Gladan ŽN, Skejić S, Despalatović M, Cvitković I, Dragičević B, Dulčić J, Vidjak O, Bojanić N, Žuljević A, Aplikioti M, Argyrou M, Josephides M, Michailidis N, Jakobsen HH, Staehr PA, Ojaveer H, Lehtiniemi M, Massé C, Zenetos A, Castriota L, Livi S, Mazziotti C, Schembri PJ, Evans J, Bartolo AG, Kabuta SH, Smolders S, Knegtering E, Gittenberger A, Gruszka P, Kraśniewski W, Bartilotti C, Tuaty-Guerra M, Canning-Clode J, Costa AC, Parente MI, Botelho AZ, Micael J, Miodonski JV, Carreira GP, Lopes V, Chainho P, Barberá C, Naddafi R, Florin AB, Barry P, Stebbing PD, Cardoso AC.

Mar Pollut Bull. 2019 Aug;145:429-435. doi: 10.1016/j.marpolbul.2019.06.012. Epub 2019 Jun 22. Review.

2.

The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?

Clemen CS, Winter L, Strucksberg KH, Berwanger C, Türk M, Kornblum C, Florin A, Aguilar-Pimentel JA, Amarie OV, Becker L, Garrett L, Hans W, Moreth K, Neff F, Pingen L, Rathkolb B, Rácz I, Rozman J, Treise I, Fuchs H, Gailus-Durner V, de Angelis MH, Vorgerd M, Eichinger L, Schröder R.

Biochem Biophys Res Commun. 2018 Sep 18;503(4):2770-2777. doi: 10.1016/j.bbrc.2018.08.038. Epub 2018 Aug 9.

3.

Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer.

Golfmann K, Meder L, Koker M, Volz C, Borchmann S, Tharun L, Dietlein F, Malchers F, Florin A, Büttner R, Rosen N, Rodrik-Outmezguine V, Hallek M, Ullrich RT.

Oncogene. 2018 Oct;37(42):5682-5693. doi: 10.1038/s41388-018-0380-3. Epub 2018 Jul 3.

PMID:
29970903
4.

Codon-specific translation reprogramming promotes resistance to targeted therapy.

Rapino F, Delaunay S, Rambow F, Zhou Z, Tharun L, De Tullio P, Sin O, Shostak K, Schmitz S, Piepers J, Ghesquière B, Karim L, Charloteaux B, Jamart D, Florin A, Lambert C, Rorive A, Jerusalem G, Leucci E, Dewaele M, Vooijs M, Leidel SA, Georges M, Voz M, Peers B, Büttner R, Marine JC, Chariot A, Close P.

Nature. 2018 Jun;558(7711):605-609. doi: 10.1038/s41586-018-0243-7. Epub 2018 Jun 20.

PMID:
29925953
5.

The Endosomal Protein CEMIP Links WNT Signaling to MEK1-ERK1/2 Activation in Selumetinib-Resistant Intestinal Organoids.

Duong HQ, Nemazanyy I, Rambow F, Tang SC, Delaunay S, Tharun L, Florin A, Büttner R, Vandaele D, Close P, Marine JC, Shostak K, Chariot A.

Cancer Res. 2018 Aug 15;78(16):4533-4548. doi: 10.1158/0008-5472.CAN-17-3149. Epub 2018 Jun 18.

6.

Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer.

Meder L, Schuldt P, Thelen M, Schmitt A, Dietlein F, Klein S, Borchmann S, Wennhold K, Vlasic I, Oberbeck S, Riedel R, Florin A, Golfmann K, Schlößer HA, Odenthal M, Buettner R, Wolf J, Hallek M, Herling M, von Bergwelt-Baildon M, Reinhardt HC, Ullrich RT.

Cancer Res. 2018 Aug 1;78(15):4270-4281. doi: 10.1158/0008-5472.CAN-17-2176. Epub 2018 May 18.

7.

LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model.

Meder L, König K, Dietlein F, Macheleidt I, Florin A, Ercanoglu MS, Rommerscheidt-Fuss U, Koker M, Schön G, Odenthal M, Klein F, Büttner R, Schulte JH, Heukamp LC, Ullrich RT.

Oncogene. 2018 May;37(20):2746-2756. doi: 10.1038/s41388-018-0158-7. Epub 2018 Mar 5.

PMID:
29503447
8.

Extraordinarily rapid speciation in a marine fish.

Momigliano P, Jokinen H, Fraimout A, Florin AB, Norkko A, Merilä J.

Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):6074-6079. doi: 10.1073/pnas.1615109114. Epub 2017 May 22.

9.

Cognitive self-regulation and social functioning among French children: A longitudinal study from kindergarten to first grade.

Hubert B, Guimard P, Florin A.

Psych J. 2017 Mar;6(1):57-75. doi: 10.1002/pchj.160.

PMID:
28371549
10.

Correction: Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine.

Ladang A, Rapino F, Heukamp LC, Tharun L, Shostak K, Hermand D, Delaunay S, Klevernic I, Jiang Z, Jacques N, Jamart D, Migeot V, Florin A, Göktuna S, Malgrange B, Sansom OJ, Nguyen L, Büttner R, Close P, Chariot A.

J Exp Med. 2017 Apr 3;214(4):1199. doi: 10.1084/jem.2014228803082017c. Epub 2017 Mar 10. No abstract available.

11.

Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer.

Delaunay S, Rapino F, Tharun L, Zhou Z, Heukamp L, Termathe M, Shostak K, Klevernic I, Florin A, Desmecht H, Desmet CJ, Nguyen L, Leidel SA, Willis AE, Büttner R, Chariot A, Close P.

J Exp Med. 2016 Oct 17;213(11):2503-2523. Epub 2016 Oct 10.

12.

LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia.

Nguyen PH, Fedorchenko O, Rosen N, Koch M, Barthel R, Winarski T, Florin A, Wunderlich FT, Reinart N, Hallek M.

Cancer Cell. 2016 Oct 10;30(4):610-622. doi: 10.1016/j.ccell.2016.09.007.

13.

Ercc1 Deficiency Promotes Tumorigenesis and Increases Cisplatin Sensitivity in a Tp53 Context-Specific Manner.

Jokić M, Vlašić I, Rinneburger M, Klümper N, Spiro J, Vogel W, Offermann A, Kümpers C, Fritz C, Schmitt A, Riabinska A, Wittersheim M, Michels S, Ozretić L, Florin A, Welcker D, Akyuz MD, Nowak M, Erkel M, Wolf J, Büttner R, Schumacher B, Thomale J, Persigehl T, Maintz D, Perner S, Reinhardt HC.

Mol Cancer Res. 2016 Nov;14(11):1110-1123. Epub 2016 Aug 11.

14.

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors.

Ortiz-Cuaran S, Scheffler M, Plenker D, Dahmen L, Scheel AH, Fernandez-Cuesta L, Meder L, Lovly CM, Persigehl T, Merkelbach-Bruse S, Bos M, Michels S, Fischer R, Albus K, König K, Schildhaus HU, Fassunke J, Ihle MA, Pasternack H, Heydt C, Becker C, Altmüller J, Ji H, Müller C, Florin A, Heuckmann JM, Nuernberg P, Ansén S, Heukamp LC, Berg J, Pao W, Peifer M, Buettner R, Wolf J, Thomas RK, Sos ML.

Clin Cancer Res. 2016 Oct 1;22(19):4837-4847. Epub 2016 Jun 1.

15.

The Prosurvival IKK-Related Kinase IKKε Integrates LPS and IL17A Signaling Cascades to Promote Wnt-Dependent Tumor Development in the Intestine.

Göktuna SI, Shostak K, Chau TL, Heukamp LC, Hennuy B, Duong HQ, Ladang A, Close P, Klevernic I, Olivier F, Florin A, Ehx G, Baron F, Vandereyken M, Rahmouni S, Vereecke L, van Loo G, Büttner R, Greten FR, Chariot A.

Cancer Res. 2016 May 1;76(9):2587-99. doi: 10.1158/0008-5472.CAN-15-1473. Epub 2016 Mar 15.

16.

Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition.

Henssen A, Althoff K, Odersky A, Beckers A, Koche R, Speleman F, Schäfers S, Bell E, Nortmeyer M, Westermann F, De Preter K, Florin A, Heukamp L, Spruessel A, Astrahanseff K, Lindner S, Sadowski N, Schramm A, Astorgues-Xerri L, Riveiro ME, Eggert A, Cvitkovic E, Schulte JH.

Clin Cancer Res. 2016 May 15;22(10):2470-81. doi: 10.1158/1078-0432.CCR-15-1449. Epub 2015 Dec 2.

17.

Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer.

Schöttle J, Chatterjee S, Volz C, Siobal M, Florin A, Rokitta D, Hinze Y, Dietlein F, Plenker D, König K, Albus K, Heuckmann JM, Rauh D, Franz T, Neumaier B, Fuhr U, Heukamp LC, Ullrich RT.

Oncotarget. 2015 Nov 17;6(36):38458-68. doi: 10.18632/oncotarget.6276.

18.

Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine.

Ladang A, Rapino F, Heukamp LC, Tharun L, Shostak K, Hermand D, Delaunay S, Klevernic I, Jiang Z, Jacques N, Jamart D, Migeot V, Florin A, Göktuna S, Malgrange B, Sansom OJ, Nguyen L, Büttner R, Close P, Chariot A.

J Exp Med. 2015 Nov 16;212(12):2057-75. doi: 10.1084/jem.20142288. Epub 2015 Nov 2. Erratum in: J Exp Med. 2017 Apr 3;214(4):1199.

19.

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.

Meder L, König K, Ozretić L, Schultheis AM, Ueckeroth F, Ade CP, Albus K, Boehm D, Rommerscheidt-Fuss U, Florin A, Buhl T, Hartmann W, Wolf J, Merkelbach-Bruse S, Eilers M, Perner S, Heukamp LC, Buettner R.

Int J Cancer. 2016 Feb 15;138(4):927-38. doi: 10.1002/ijc.29835. Epub 2015 Sep 25.

20.

Papillary thyroid carcinoma with anaplastic dedifferentiation in the lymph node metastasis - a rare form of presentation even for a tall cell variant.

Barbu CG, Florin A, Neamţu MC, Avramescu ET, Terzea D, Miron A, Dănciulescu Miulescu R, Poiană C, Fica S.

Rom J Morphol Embryol. 2015;56(2):527-31.

21.

The Association of Urbanicity with Cognitive Development at Five Years of Age in Preterm Children.

Gouin M, Flamant C, Gascoin G, Rouger V, Florin A, Guimard P, Rozé JC, Hanf M.

PLoS One. 2015 Jul 10;10(7):e0131749. doi: 10.1371/journal.pone.0131749. eCollection 2015.

22.

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients.

König K, Peifer M, Fassunke J, Ihle MA, Künstlinger H, Heydt C, Stamm K, Ueckeroth F, Vollbrecht C, Bos M, Gardizi M, Scheffler M, Nogova L, Leenders F, Albus K, Meder L, Becker K, Florin A, Rommerscheidt-Fuss U, Altmüller J, Kloth M, Nürnberg P, Henkel T, Bikár SE, Sos ML, Geese WJ, Strauss L, Ko YD, Gerigk U, Odenthal M, Zander T, Wolf J, Merkelbach-Bruse S, Buettner R, Heukamp LC.

J Thorac Oncol. 2015 Jul;10(7):1049-57. doi: 10.1097/JTO.0000000000000570.

23.

Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer.

Kloth M, Ruesseler V, Engel C, Koenig K, Peifer M, Mariotti E, Kuenstlinger H, Florin A, Rommerscheidt-Fuss U, Koitzsch U, Wodtke C, Ueckeroth F, Holzapfel S, Aretz S, Propping P, Loeffler M, Merkelbach-Bruse S, Odenthal M, Friedrichs N, Heukamp LC, Zander T, Buettner R.

Gut. 2016 Aug;65(8):1296-305. doi: 10.1136/gutjnl-2014-309026. Epub 2015 Apr 28.

PMID:
26001389
24.

Enhanced FHL2 and TGF-β1 Expression Is Associated With Invasive Growth and Poor Survival in Malignant Melanomas.

Westphal P, Mauch C, Florin A, Czerwitzki J, Olligschläger N, Wodtke C, Schüle R, Büttner R, Friedrichs N.

Am J Clin Pathol. 2015 Feb;143(2):248-56; quiz 307. doi: 10.1309/AJCPXEC6CIT2TXAF.

PMID:
25596251
25.

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies.

Althoff K, Beckers A, Bell E, Nortmeyer M, Thor T, Sprüssel A, Lindner S, De Preter K, Florin A, Heukamp LC, Klein-Hitpass L, Astrahantseff K, Kumps C, Speleman F, Eggert A, Westermann F, Schramm A, Schulte JH.

Oncogene. 2015 Jun;34(26):3357-68. doi: 10.1038/onc.2014.269. Epub 2014 Sep 1.

26.

Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.

Lovly CM, McDonald NT, Chen H, Ortiz-Cuaran S, Heukamp LC, Yan Y, Florin A, Ozretić L, Lim D, Wang L, Chen Z, Chen X, Lu P, Paik PK, Shen R, Jin H, Buettner R, Ansén S, Perner S, Brockmann M, Bos M, Wolf J, Gardizi M, Wright GM, Solomon B, Russell PA, Rogers TM, Suehara Y, Red-Brewer M, Tieu R, de Stanchina E, Wang Q, Zhao Z, Johnson DH, Horn L, Wong KK, Thomas RK, Ladanyi M, Pao W.

Nat Med. 2014 Sep;20(9):1027-34. doi: 10.1038/nm.3667. Epub 2014 Aug 31.

27.

Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma.

Schütte U, Bisht S, Heukamp LC, Kebschull M, Florin A, Haarmann J, Hoffmann P, Bendas G, Buettner R, Brossart P, Feldmann G.

Transl Oncol. 2014 Apr;7(2):309-21. doi: 10.1016/j.tranon.2014.02.005. Epub 2014 Mar 4.

28.

Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer.

Chatterjee S, Wieczorek C, Schöttle J, Siobal M, Hinze Y, Franz T, Florin A, Adamczak J, Heukamp LC, Neumaier B, Ullrich RT.

Cancer Res. 2014 May 15;74(10):2816-24. doi: 10.1158/0008-5472.CAN-13-2986. Epub 2014 Mar 27.

29.

Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.

Malchers F, Dietlein F, Schöttle J, Lu X, Nogova L, Albus K, Fernandez-Cuesta L, Heuckmann JM, Gautschi O, Diebold J, Plenker D, Gardizi M, Scheffler M, Bos M, Seidel D, Leenders F, Richters A, Peifer M, Florin A, Mainkar PS, Karre N, Chandrasekhar S, George J, Silling S, Rauh D, Zander T, Ullrich RT, Reinhardt HC, Ringeisen F, Büttner R, Heukamp LC, Wolf J, Thomas RK.

Cancer Discov. 2014 Feb;4(2):246-57. doi: 10.1158/2159-8290.CD-13-0323. Epub 2013 Dec 3.

30.

Effects of a large northern European no-take zone on flatfish populations.

Florin AB, Bergström U, Ustups D, Lundström K, Jonsson PR.

J Fish Biol. 2013 Oct;83(4):939-62. doi: 10.1111/jfb.12097. Epub 2013 May 31.

PMID:
24090556
31.

Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse model.

König K, Meder L, Kröger C, Diehl L, Florin A, Rommerscheidt-Fuss U, Kahl P, Wardelmann E, Magin TM, Buettner R, Heukamp LC.

PLoS One. 2013;8(3):e57996. doi: 10.1371/journal.pone.0057996. Epub 2013 Mar 11.

32.

The Global School Adaptation score: a new neurodevelopmental assessment tool for very preterm children at five years of age.

Boussicault G, Nguyen The Tich S, Branger B, Guimard P, Florin A, Rozé JC, Flamant C.

J Pediatr. 2013 Aug;163(2):460-4. doi: 10.1016/j.jpeds.2013.01.052. Epub 2013 Feb 28.

PMID:
23453546
33.

Posttraumatic growth in long term breast cancer survivors: relation to coping, social support and cognitive processing.

Lelorain S, Tessier P, Florin A, Bonnaud-Antignac A.

J Health Psychol. 2012 Jul;17(5):627-39. doi: 10.1177/1359105311427475. Epub 2011 Nov 18.

PMID:
22100393
34.

Predicting mental quality of life in breast cancer survivors using comparison participants.

Lelorain S, Tessier P, Florin A, Bonnaud-Antignac A.

J Psychosoc Oncol. 2011;29(4):430-49.

PMID:
21966726
35.

Evaluation of effects caused by differentially spliced Ets-1 transcripts in fibroblasts.

Hahne JC, Fuchs T, Florin A, Edwards D, Pourtier A, Soncin F, Wernert N.

Int J Oncol. 2011 Nov;39(5):1073-82. doi: 10.3892/ijo.2011.1152. Epub 2011 Aug 9.

PMID:
21833469
36.

Genetic population structure of perch Perca fluviatilis along the Swedish coast of the Baltic Sea.

Olsson J, Mo K, Florin AB, Aho T, Ryman N.

J Fish Biol. 2011 Jul;79(1):122-37. doi: 10.1111/j.1095-8649.2011.02998.x. Epub 2011 May 12.

PMID:
21722115
37.

Identification of ETS-1 target genes in human fibroblasts.

Hahne JC, Okuducu AF, Fuchs T, Florin A, Wernert N.

Int J Oncol. 2011 Jun;38(6):1645-52. doi: 10.3892/ijo.2011.981. Epub 2011 Mar 21.

PMID:
21424123
38.

Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells.

Shaikhibrahim Z, Langer B, Lindstrot A, Florin A, Bosserhoff A, Buettner R, Wernert N.

Oncol Rep. 2011 Apr;25(4):1125-9. doi: 10.3892/or.2011.1156. Epub 2011 Jan 21.

PMID:
21258770
39.

Long term posttraumatic growth after breast cancer: prevalence, predictors and relationships with psychological health.

Lelorain S, Bonnaud-Antignac A, Florin A.

J Clin Psychol Med Settings. 2010 Mar;17(1):14-22. doi: 10.1007/s10880-009-9183-6.

PMID:
20082122
40.

Identification, characterisation and regulation by CD40 activation of novel CD95 splice variants in CD95-apoptosis-resistant, human, B-cell non-Hodgkin's lymphoma.

Lajmanovich A, Ribeyron JB, Florin A, Fournier A, Pasquier MA, Duley S, Chauvet M, Plumas J, Bonnefoix T, Gressin R, Leroux D, Callanan MB.

Exp Cell Res. 2009 Nov 15;315(19):3281-93. doi: 10.1016/j.yexcr.2009.09.008. Epub 2009 Sep 12.

PMID:
19751723
41.

Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes.

Sahin A, Vercamer C, Kaminski A, Fuchs T, Florin A, Hahne JC, Mattot V, Pourtier-Manzanedo A, Pietsch T, Fafeur V, Wernert N.

Int J Oncol. 2009 Feb;34(2):377-89.

PMID:
19148472
42.

Population structure of flounder (Platichthys flesus) in the Baltic Sea: differences among demersal and pelagic spawners.

Florin AB, Höglund J.

Heredity (Edinb). 2008 Jul;101(1):27-38. doi: 10.1038/hdy.2008.22. Epub 2008 May 7.

43.

Alterations of Sertoli cell activity in the long-term testicular germ cell death process induced by fetal androgen disruption.

Benbrahim-Tallaa L, Siddeek B, Bozec A, Tronchon V, Florin A, Friry C, Tabone E, Mauduit C, Benahmed M.

J Endocrinol. 2008 Jan;196(1):21-31. doi: 10.1677/JOE-07-0062.

PMID:
18180314
44.

Genetics and epigenetics of 1q rearrangements in hematological malignancies.

Fournier A, Florin A, Lefebvre C, Solly F, Leroux D, Callanan MB.

Cytogenet Genome Res. 2007;118(2-4):320-7. Review.

PMID:
18000386
45.

Absence of population structure of turbot (Psetta maxima) in the Baltic Sea.

Florin AB, Höglund J.

Mol Ecol. 2007 Jan;16(1):115-26.

PMID:
17181725
46.

Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones.

Lefebvre C, Fabre B, Vettier C, Rabin L, Florin A, Wang J, Gressin R, Jacob MC, Callanan M, Leroux D.

Hum Pathol. 2007 Apr;38(4):660-7. Epub 2006 Nov 28.

PMID:
17134739
47.

Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.

Kaminski A, Hahne JC, Haddouti el-M, Florin A, Wellmann A, Wernert N.

Int J Mol Med. 2006 Nov;18(5):941-50.

PMID:
17016625
48.

[Long-term effects of environmental endocrine disruptors on male fertility].

Mauduit C, Florin A, Amara S, Bozec A, Siddeek B, Cunha S, Meunier L, Selva J, Albert M, Vialard F, Bailly M, Benahmed M.

Gynecol Obstet Fertil. 2006 Oct;34(10):978-84. Epub 2006 Sep 25. Review. French.

PMID:
16996771
49.

99mTechnetium-SESTAMIBI uptake in malignant lymphomas. Correlation with chemotherapy response.

Lazarowski A, Dupont J, Fernández J, Garay G, Florín A, Solimano J, Riveros D, Cacchione R.

Lymphat Res Biol. 2006 Spring;4(1):23-8.

PMID:
16569203
50.

TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.

Vindrieux D, Réveiller M, Florin A, Blanchard C, Ruffion A, Devonec M, Benahmed M, Grataroli R.

J Cell Physiol. 2006 Mar;206(3):709-17.

PMID:
16245307

Supplemental Content

Loading ...
Support Center